Ostrowski Erik 4
4 · Akebia Therapeutics, Inc. · Filed Jul 1, 2025
Insider Transaction Report
Form 4
Ostrowski Erik
SVP, CFO, CBO & Treasurer
Transactions
- Sale
Common Stock
2025-06-30$3.67/sh−41,314$151,622→ 503,586 total
Footnotes (2)
- [F1]This sale was made pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on June 21, 2024.
- [F2]This sale was made automatically by the Issuer to cover tax withholding obligations in connection with the vesting and settlement of one-third of the reporting person's restricted stock units granted on June 28, 2024.